- Home
- LVRO vs KROS Comparison
LVRO vs KROS Comparison
Compare LVRO & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LVRO | KROS |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.2M | 655.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LVRO | KROS |
|---|---|---|
| Price | $1.13 | $17.54 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 12 |
| Target Price | $1.88 | ★ $22.20 |
| AVG Volume (30 Days) | ★ 6.0M | 597.1K |
| Earning Date | 02-02-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.57 |
| Revenue | ★ $1,667,345,189.00 | $246,718,000.00 |
| Revenue This Year | N/A | $6,924.79 |
| Revenue Next Year | $11.45 | N/A |
| P/E Ratio | ★ N/A | $11.38 |
| Revenue Growth | N/A | ★ 37798.31 |
| 52 Week Low | $0.19 | $9.12 |
| 52 Week High | $5.43 | $22.55 |
Technical Indicators
Market Signals| Indicator | LVRO | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 61.58 | 34.82 |
| Support Level | $0.19 | $19.76 |
| Resistance Level | $1.49 | $21.76 |
| Average True Range (ATR) | 0.19 | 0.81 |
| MACD | 0.09 | -0.55 |
| Stochastic Oscillator | 69.98 | 2.35 |
Price Performance
Historical ComparisonAbout LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.